The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
CONQUERING THE INTOLERABLE BURDEN OF MALARIA: WHAT’S NEW, WHAT’S NEEDED: A SUMMARY
Open accessAbstract
Each year, up to three million deaths due to malaria and close to five billion episodes of clinical illness possibly meriting antimalarial therapy occur throughout the world, with Africa having more than 90% of this burden. Almost 3% of disability adjusted life years are due to malaria mortality globally, 10% in Africa. New information is presented in this supplement on malaria-related perinatal mortality, occurrence of human immunodeficiency virus in pregnancy, undernutrition, and neurologic, cognitive, and developmental sequelae. The entomologic determinants of transmission and uses of modeling for program planning and disease prediction and prevention are discussed. New data are presented from the Democratic Republic of the Congo, Tanzania, Ethiopia, and Zimbabwe on the increasing urban malaria problem and on epidemic malaria. Between 6% and 28% of the malaria burden may occur in cities, which comprise less than 2% of the African surface. Macroeconomic projections show that the costs are far greater than the costs of individual cases, with a substantial deleterious impact of malaria on schooling of patients, external investments into endemic countries, and tourism. Poor populations are at greatest risk; 58% of the cases occur in the poorest 20% of the world's population and these patients receive the worst care and have catastrophic economic consequences from their illness. This social vulnerability requires better understanding for improving deployment, access, quality, and use of effective interventions. Studies from Ghana and elsewhere indicate that for every patient with febrile illness assumed to be malaria seen in health facilities, 4-5 episodes occur in the community. Effective actions for malaria control mandate rational public policies; market forces, which often drive sales and use of drugs and other interventions, are unlikely to guarantee their use. Artemisinin-based combination therapy (ACT) for malaria is rapidly gaining acceptance as an effective approach for countering the spread and intensity of Plasmodium falciparum resistance to chloroquine, sulfadoxine/pyrimethamine, and other antimalarial drugs. Although costly, ACT ($1.20-2.50 per adult treatment) becomes more cost-effective as resistance to alternative drugs increases; early use of ACT may delay development of resistance to these drugs and prevent the medical toll associated with use of ineffective drugs. The burden of malaria in one district in Tanzania has not decreased since the primary health care approach replaced the vertical malaria control efforts of the 1960s. Despite decentralization, this situation resulted, in part, from weak district management capacity, poor coordination, inadequate monitoring, and lack of training of key staff. Experience in the Solomon Islands showed that spraying with DDT, use of insecticide-treated bed nets (ITNs), and health education were all associated with disease reduction. The use of nets permitted a reduction in DDT spraying, but could not replace it without an increased malaria incidence. Baseline data and reliable monitoring of key outcome indicators are needed to measure whether the ambitious goals for the control of malaria and other diseases has occurred. Such systems are being used for evidence-based decision making in Tanzania and several other countries. Baseline cluster sampling surveys in several countries across Africa indicate that only 53% of the children with febrile illness in malarious areas are being treated; chloroquine (CQ) is used 84% of the time, even where the drug may be ineffective. Insecticide-treated bed nets were used only 2% of the time by children less than five years of age. Progress in malaria vaccine research has been substantial over the past five years; 35 candidate malaria vaccines are in development, many of which are in clinical trials. Development of new vaccines and drugs has been the result of increased investments and formation of public-private partnerships. Before malaria vaccine becomes deployed, consideration must be given to disease burden, cost-effectiveness, financing, delivery systems, and approval by regulatory agencies. Key to evaluation of vaccine effectiveness will be collection and prompt analysis of epidemiologic information. Training of persons in every aspect of malaria research and control is essential for programs to succeed. The Multilateral Initiative on Malaria (MIM) is actively promoting research capacity strengthening and has established networks of institutions and scientists throughout the African continent, most of whom are now linked by modern information-sharing networks. Evidence over the past century is that successful control malaria programs have been linked to strong research activities. To ensure effective coordination and cooperation between the growing number of research and control coalitions forming in support of malaria activities, an umbrella group is needed. With continued support for scientists and control wo
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“where a lack of flexibility, an incapacity to adapt to changing situations, and a lack of coordination between control programmes and research institutions have all been identified as important obstacles to advancement in malaria control and elimination [17],[21],[22].”
From Some Lessons for the Future from the Global Malaria Eradication Programme (1955–1969) (2011) · cites this paper as [22]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The World Health Report 2002 - Reducing Risks, Promoting Healthy Life
Not Available, N. A. (2003) · Education for Health: Change in Learning & Practice · doi:10.1080/1357628031000116808 · Cited by 6,046
The economic burden of malaria
Gallup, J., & Sachs, J. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.85 · Cited by 1,480
The Epidemiology and Control of Malaria
(1960) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1960.tb105313.x · Cited by 1,255
Indicators of Life-Threatening Malaria in African Children
Marsh, K., Forster, D., Waruiru, C., Mwangi, I., Winstanley, M., Marsh, V., Newton, C., Winstanley, P., Warn, P., Peshu, N., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322102 · Cited by 1,097
The global distribution and population at risk of malaria: past, present, and future
Hay, S. I., Guerra, C. A., Tatem, A. J., Noor, A. M., & Snow, R. W. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01043-6 · Cited by 1,001
The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden
Breman, J. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.1 · Cited by 931
A Climate-based Distribution Model of Malaria Transmission in Sub-Saharan Africa
Craig, M. H., Snow, R. W., & le Sueur, D. (1999) · Parasitology Today · doi:10.1016/s0169-4758(99)01396-4 · Cited by 854 · cited 2×
“Malaria risk areas in Africa according to climate suitability.(5,31) White class 1, no transmission; yellow class 2, marginal risks, uncommon transmission in an average year; orange class 3, acute seasonal transmission with a tendency toward epidemics; brown class 4, stable endemic transmission.”
BackgroundSnow, R. W., Craig, M., Deichmann, U., & Marsh, K. (1999) · PubMed · Cited by 735
Hoffman, S. L., Goh, L. M. L., Luke, T. C., Schneider, I., Le, T. P., Doolan, D. L., Sacci, J., de la Vega, P., Dowler, M., Paul, C., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/339409 · Cited by 688
RUSSELL, S. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.147 · Cited by 650
Research works printed but not linked: 52
- 2000, 320, 1228
- 2001, 64, 1
- 2001, 64, 1
- 2001, 64, 57
- 2004, 4, 327
- 1995, 332, 1399
- 2004, 71, 16
- 1992, 340, 524
- 2004, 71, 25
- 2004, 71, 35
- 2004, 71, 41
- 2004, 71, 55
- 2004, 71, 64
- 2004, 71, 71
- 2004, 71, 80
- 2004, 71, 87
- 2004, 71, 94
- 2001, 17, 558
- 2004, 71, 97
- 2004, 71, 103
- 2004, 71, 118
- 1999, 77, 624
- 2004, 71, 128
- 1995, 15, 105
- 2004, 71, 136
- 2001, 64, 85
- 2004, 71, 147
- 2004, 71, 141
- 2004, 71, 156
- 2004, 71, 162
- 2004, 71, 168
- 2004, 71, 174
- 2004, 71, 179
- 2001, 64, 12
- 2004, 98, 15
- 1999, 354, 739
- 2004, 71, 187
- 2004, 71, 196
- 1991, 42, 199
- 2003, 19, 363
- 2004, 71, 205
- 2004, 71, 214
- 2004, 71, 224
- 1994, 72, 371
- 2004, 71, 232
- 2004, 71, 239
- 2002, 185, 1155
- 2004, 71, 248
- 2004, 71, 253
- 2004, 71, 259
- 2004, 71, 268
- 2004, 71, 279
Cited by
Anaemia in low-income and middle-income countries
Balarajan, Y., Ramakrishnan, U., Özaltin, E., Shankar, A. H., & Subramanian, S. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62304-5 · Cited by 1,304
Doolan, D. L., Dobaño, C., & Baird, J. K. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00025-08 · Cited by 1,301
Vivax Malaria: Neglected and Not Benign
Price, R. N., Tjitra, E., Guerra, C. A., Yeung, S., White, N. J., & Anstey, N. M. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.79 · Cited by 838
Alonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Milman, J., Mandomando, I., Spiessens, B., Guinovart, C., Espasa, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17223-1 · Cited by 752
Evolutionary rescue in a changing world
Carlson, S. M., Cunningham, C. J., & Westley, P. A. H. (2014) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2014.06.005 · Cited by 716
Metadata
- Authors
- BREMAN, J. G., ALILIO, M. S., & MILLS, A.
- Affiliations
- National Institutes of Health (US)
- ORCID
- MILLS, ANNE
- Venue
- The American Journal of Tropical Medicine and Hygiene
- Published
- 2004-08
- Volume
- 71
- Issue
- 2_suppl
- Pages
- 1-15
- ISSN
- 0002-9637 (ISSN-L)
- OpenAlex
- W1871026043
- Cited by
- 677
- References
- 56
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 7 · 2023: 11 · 2022: 7 · 2021: 10 · 2020: 10 · 2019: 5 · 2018: 13 · 2017: 22 · 2016: 16 · 2015: 33 · 2014: 29 · 2013: 52 · 2012: 52
- FWCI
- 62.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal of Tropical Medicine and Hygiene (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Social Sciences › Arts and Humanities › History › History of Medicine and Tropical Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Keywords
- malaria, malaria burden, perinatal mortality, HIV in pregnancy, malnutrition, neurological sequelae, urban malaria, epidemic malaria, artemisinin-based combination therapy, antimalarial drug resistance, Plasmodium falciparum, malaria control policy, primary care, decentralization, malaria surveillance
- MeSH terms
- Africa, Antimalarials, Delivery of Health Care, Humans, Insect Control, Malaria, Medically Underserved Area, Preventive Health Services, Global Health, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CONQUERING THE INTOLERABLE BURDEN OF MALARIA: WHAT’S NEW, WHAT’S NEEDED: A SUMMARY. https://app.cochat.ai/papers/10.4269/ajtmh.2004.71.2_suppl.0700001
- The paper
- BREMAN, J. G., ALILIO, M. S., & MILLS, A. (2004). CONQUERING THE INTOLERABLE BURDEN OF MALARIA: WHAT’S NEW, WHAT’S NEEDED: A SUMMARY. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.2004.71.2_suppl.0700001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.